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A 43-year-old man was admitted with central chest pain and ECG changes suggesting an acute 
coronary syndrome. On review, he had firm non-tender nodules on the dorsum of both hands. These 




1. What is the physical sign shown and what is the likely diagnosis? 
2. What are the causes, complications and prognosis of this condition? 
3. How is this condition diagnosed and is there a role for screening? 
 




This image shows xanthoma of the extensor tendons of the hands. The Achilles tendon can also be 
affected. It occurs secondary to prolonged hypercholesterolaemia where lipids infiltrate the tendon 
and the surrounding sheath leading to irregular thickening [1]. It is most commonly seen in familial 
hypercholesterolaemia (FH), but can be found in other rare hereditary disorders such as 




FH is the most common dominantly inherited genetic disorder [3]. It is typically caused by 
mutations affecting function of the low-density lipoprotein (LDL) receptor, resulting in markedly 
raised LDL-cholesterol levels from birth [4]. Up to 50% of untreated men and 30% of untreated 
women will have a myocardial infarction by the age of 50 and 60 years respectively [5,6]. Effective 




Only a minority of people with FH have clinical signs. FH should be suspected in people with a 
total cholesterol above 7.5 mmol/L (and/or LDL-cholesterol over 4.9 mmol/L) and a history of 
ischaemic heart disease (IHD) before the age of 60 or a family history of IHD in first degree 
relatives under the age of 60 (or second degree relatives under the age of 50) [8]. Genetic testing is 
available in parts of the UK, however, not all causative mutations are known and so a negative test 
does not refute the clinical diagnosis. NICE recommends using the Dutch Lipid Clinic Network 
Criteria (DLCNC), or Simon Broome criteria to make a diagnosis of FH in primary care [9].  
 
Despite the life-threatening complications and the availability of effective treatment, FH remains 
massively underdiagnosed [10]. Several screening tools have been considered in different settings 
including primary care, paediatrics, coronary care units and biochemistry laboratories. In Wales 
there is a programme of ‘cascade screening’ with FH specialist nurses attached to lipid clinics using 
cholesterol testing and, when appropriate, genetic testing to follow up relatives of index cases with 
possible or definite FH. This is supplemented by specialist paediatric lipid clinics to manage 





1. Tendon xanthoma are most commonly caused by FH. 
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